Chinook Therapeutics Inc

NASDAQ:KDNY  
24.08
-1.27 (-5.01%)
4:01:50 PM EDT: $24.08 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.46B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.11 Million
Adjusted EPS-$0.79
See more estimates
10-Day MA$25.11
50-Day MA$24.58
200-Day MA$20.25
See more pivots

Chinook Therapeutics Inc Stock, NASDAQ:KDNY

400 Fairview Avenue North, Suite 900, Seattle, Washington 98109
United States of America
Phone: +1.206.485.7241
Number of Employees: 138

Description

Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing, and commercializing precision medicines for rare, severe chronic kidney diseases. The company was founded in 2019 and is headquartered in Seattle, WA.